MICHAEL J FLINTROP

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease SYRACUSE, NY NPI 1376581702

General Payments — all program years on this page

$7,191.17

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 428
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $455.79 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $423.3120
Education $32.482

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $2,047.46127
2019 $2,155.01141
2020 $510.8342
2021 $757.7458
2022 $529.4011
2023 $734.9427
2024 $455.7922

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089563416 Insmed, Inc. $16.24 02/06/2024 Education Undisputed 01/23/2026 View at CMS
1089570660 Insmed, Inc. $16.24 06/26/2024 Education Undisputed 01/23/2026 View at CMS
1104294776 AstraZeneca Pharmaceuticals LP $16.26 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105567576 AstraZeneca Pharmaceuticals LP $27.13 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116286749 GlaxoSmithKline, LLC. $23.01 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116352702 GlaxoSmithKline, LLC. $30.10 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116625940 GlaxoSmithKline, LLC. $16.40 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116655021 GlaxoSmithKline, LLC. $25.01 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120651115 Baxter Healthcare $18.97 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120651117 Baxter Healthcare $21.78 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120651119 Baxter Healthcare $20.96 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124746459 Grifols USA, LLC $20.74 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124746461 Grifols USA, LLC $20.95 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137548655 Takeda Pharmaceuticals U.S.A., Inc. $19.41 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137889794 Electromed, Inc. $20.89 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137889799 Electromed, Inc. $16.43 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139599241 GENZYME CORPORATION $22.45 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141848592 Merck Sharp & Dohme LLC $28.65 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144987851 INOGEN, INC. $14.41 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144987853 INOGEN, INC. $12.60 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145071835 Mallinckrodt Hospital Products Inc. $27.93 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148304536 Axsome Therapeutics, Inc. $19.23 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.